Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility…
Mental health treatment provider Emyria (ASX: EMD) has announced that its psychiatry specialist has been granted "Authorised Prescriber" status by…
As news of billionaire (and controversial) business magnate Elon Musk taking “microdoses of ketamine (a dissociative drug)” to manage depression…
If you read my articles often, you would know that I can become quite laudatory when discussing small cap companies…
Harbouring more MDMA than music festival goers, the University of Western Australia (UWA) is leading the way in research around…
Pharmaceuticals company Emyria (ASX: EMD) is set to commence the regulatory process of registering their cannabinoid-based medicine EMD-003 as a…